PCAAD - Other Resources

Program in Child Affective
and Anxiety Disorders

PCAAD > Studies > POTS II

Does your child suffer from
Obsessive Compulsive Disorder (OCD)?

Many children and adolescents who take medication for OCD still suffer from OCD symptoms that can interfere with school, work, and relationships with family and friends.

Dr. John March , at Duke University, Dr. Martin Franklin , at the University of Pennsylvania, and Dr. Henrietta Leonard , at Brown University, are conducting a multi-site study evaluating the effectiveness of adding two different types of Cognitive-Behavioral Therapy (CBT) to ongoing medication management for the treatment of pediatric OCD that does not respond completely to medication treatment.

Participants in this study will receive medication management free of charge. In addition, they may be assigned to receive CBT at no cost from a psychiatrist or a psychologist.

Children ages 7-17 with a diagnosis of OCD who are take one of the following medications and who still have residual OCD symptoms may be eligible. Eligible medications include fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), clomipramine (Anafranil), citalopram (Celexa), escitalopram (Lexapro), and venlafaxine (Effexor). Participants must live within commuting distance of Raleigh/Durham, NC, Providence, RI, or Philadelphia, PA.

Contact Information

City	Program	Contact	Phone	Email
Philadelphia, PA	University of Pennsylvania	Sophia Talbott	(215) 746-3337	talbott@mail.med.upenn.edu
Durham, NC	Duke University Medical Center	Jeff Sapyta, Ph.D.	(919) 416-2451	jeffrey.sapyta@duke.edu
Durham, NC	Duke University Medical Center	Rebecca Dingfelder, Ph.D.	(919) 416-2447	dingf002@mc.duke.edu
Providence, RI	Brown University	Noah Berman	(401) 444-2178	nberman@lifespan.org

Duke University
Medical Center